Bright News

  ·          Profit After Tax (PAT) increased by 22.81% to ₹ 13,492 crore. ·          Value of New Business (VNB) increased by 61.32% to ₹3,136 crore. ·          VNB Margin (Net) increased by 750 bps to 22.9%. ·          Total Premium Income increased by 6.75% to ₹ 1,27,250 crore. ·          Individual New business premium income increased by 14.48% to ₹ 14,351 crore. ·          Overall APE at ₹ 13,692 crore registering increase of 8.22%. ·          Non Par APE within Individual Business increased by 14.24% to ₹ 2,447 crore. ·          Group Business APE increased by 10.20% to ₹ 6,160 crore. ·          Non Par APE share within I...

  Built for the way India works, learns, and creates with laptop-like productivity and tablet-like flexibility News Highlights: Designed for students, first-time users, and professionals on the move Comes with a detachable keyboard for a versatile experience Qualcomm Snapdragon processors  and Android 16 deliver a familiar, intuitive experience NEW DELHI, August 6, 2026 - HP India today announced the availability of the HP OmniPad 12, an India-first device designed for the way people learn, work, and create. Combining the productivity of a laptop with the portability of a tablet, the HP OmniPad 12 offers users the flexibility to seamlessly switch between work and play.   Designed for students, first-time users, MSMEs and young professionals, the HP OmniPad 12 is built to support modern learning, collaboration, and everyday productivity. Whether attending virtual classes, managing business tasks or creating content on the go, the device delivers a versatile 2-in-1 experi...

Mumbai, 5 August, 2026: Shares of Bengaluru-based Manipal Health Enterprises Limited, which is the largest pan-India multispecialty hospital network by bed capacity as of March 31, 2026 (Source: CRISIL Report), listed at Rs 655 on the BSE with a premium of 11% to the IPO price. The scrip reached a high of Rs 675.80 on the NSE, and Rs 676.05 on the BSE. The scrip closed at Rs 663.15 on the NSE and Rs 666.70 on BSE. As per NSE, the total quantity traded stood at 470.08 lakh shares, on BSE the total Quantity stood at 43.91 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 3,365.86 crore. The Market Capitalisation of the Company at today’s closing price stood at Rs 87,696.20 crore as per BSE and Rs 87,229.24 crore as per NSE. The issue received bids of 44,30,73,025 equity shares against the offered 9,00,88,286 equity shares, according to data available on the stock exchanges. Qualified Institutional Buyers (QIB) and Retail Portion were subscribed 8.25 times and 0.93 times, respec...

Mumbai, 3 August, 2026: Mumbai-based Encube Ethicals Limited has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Initial Public Offering (IPO). The IPO, with a face value of Re 1, is a complete offer for sale of Rs 3000 crore by promoters – Mehul Madhusudan Shah, and Investor Selling Shareholder - Frontier Investment Holdings Pte. Ltd. The issue is being made through the book-building process, in line with SEBI ICDR Regulations, wherein not more than 50% reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for Retail Individual Investors (RIIs). About the Company Incorporated in 1995, the company is global specialty pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms, serving 50 countries including regulated markets such as the United States, UK and Euro...